Abstract:Interleukin-6 (IL-6), a pleriotropic cytokine, is proposed to play a crucial role in inflammatory response (ref). Further study shows that IL-6 also plays important roles during angiogenesis and vascular remodelling, depending upon cell types. We investigated the effects of IL-6 on a major cell type crucial for remodelling, human cerebral vascular smooth muscle cells (HCSMCs). HCSMCs were grown to confluence on gelatin coated 35 mm dishes and then treated with IL-6 protein at different concentrations (25–200 ng/ml). HCSMC proliferation was determined using a BrdU assay kit, and migration was determined using a HCSMC invasion assay. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor, the kinase insert domain–containing receptor (KDR), and matrix metalloproteinase (MMP)-3, -9 protein and mRNA levels were determined using Western blot analysis, ELISA, and real time –polymerase chain reaction (RT-PCR) assay, respectively. MMP-9 activity was determined using MMP zymography. VEGF had a minimal mitogenic effect on HCSMCs. However, IL-6 induced HCSMC proliferation and migration in a dose dependent manner. To explore the signal transduction pathway for the effect of IL-6 on HCSMC proliferation, we studied the downstream factor expression in HCSMCs (VEGF, MMP-3, -9). IL-6 significantly enhanced VEGF, MMP-3, -9 both mRNA and protein expression levels in HCSMCs compared with the control (without IL-6 treatment, p<0.05), respectively. Neutralizing or inhibiting IL-6 and/or VEGF using antibodies or inhibitors could block IL-6 induced HCSMC proliferation. Importantly, we demonstrated that IL-6 directly activated KDR phosphorylation in the IL-6 treated HCSMCs. Blocking KDR abolished IL-6 induced HCSMC proliferation. Our results indicate that the IL-6 treatment accelerated HCSMC proliferation through stimulation of the VEGF-KDR-MMP signal pathway. We provide the first evidence that IL-6, by triggering KDR phosphorylation, plays an important role in IL-6 induced HCSMC proliferation. HCSMC-derived MMPs could be an additional source of proteases to digest vascular basement membranes, potentially providing a key step in the initial stage of brain angiogenesis. MMPs may also contribute to HCSMC migration in angiogenesis. Supported by NIH grants: PO1 NS and RO1 NS27713 (WLY) and R21 NS45123 (GYY)

The 5-Hydroxytryptamine Transporter Is Functional In Human Coronary Artery Smooth Muscle Cells Proliferation And Is Regulated By Interleukin-1 Beta

Effect of homocysteine on expression of interleukin-6 and NF-kappa B activity in cultured rat vascular smooth muscle cells

5-HT Promotes Pulmonary Arterial Smooth Muscle Cell Proliferation Through the TRPC Channel.

Vesicle Mir-195 Derived from Endothelial Cells Inhibits Expression of Serotonin Transporter in Vessel Smooth Muscle Cells

The 5‐HT transporter transactivates the PDGFβ receptor in pulmonary artery smooth muscle cells

Mechanism of coronary artery constriction induced by 5-HT

HOMOCYSTEINE INDUCES THE PROLIFERATION OF VESSEL SMOOTH MUSCLE CELLS MEDIATED BY MITOGEN-ACTIVATED PROTEIN KINASE

Serotonin and its transporter on proliferation of fetal heart cells.

Upregulation of 5-Hydroxytryptamine Receptor Signaling in Coronary Arteries after Organ Culture

Inhibition of 5‐hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the Β‐arrestin2–mammalian Target of Rapamycin/p70S6K Pathway

The proliferation of human T lymphoblastic cells induced by 5-HT1B receptors activation is regulated by 5-HT-moduline

5-Hydroxytryptamine Enhances the Pacemaker Activity of Interstitial Cells of Cajal in Mouse Colon

Gap junction function in vascular smooth muscle: influence of serotonin

The Effects of Proinflammatory Cytokines on Expression of Serotonin Transporters in Human Enterocyte-Like Cell Line

Interleukin-6 triggers human cerebral smooth muscle cell proliferation

Serotonin transporter and serotonin receptors

Role of NOX/ROS in 5-Ht-mediated Proliferation of Rat Pulmonary Artery Smooth Muscle Cells

Transcriptional Up-Regulation In Expression Of 5-Hydroxytryptamine(2a) And Transcriptional Down-Regulation Of Angiotensin Ii Type 1 Receptors During Organ Culture Of Rat Mesenteric Artery

Human vascular smooth muscle cells possess functional CCR5

[Expression of 5-Hydroxytamine Receptors in Hepatic Stellate Cell and Action of 5-Hydroxytamine on Biological Characteristics of Hepatic Stellate Cell].

5-HT Induces PPAR Γ Reduction and Proliferation of Pulmonary Artery Smooth Muscle Cells Via Modulating GSK-3β/β-catenin Pathway